The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K. Support side: Insider open-market buy — insiders or holders bought while this setup is live; see the timeline.
Radar 78 (high attention) · dilution pressure high · listing risk low · governance risk low · runway 4.7 mo · strongest signal: Unregistered sale (Aug 6, 2026)
What would confirm: 424B5/8-K announcing an offering, ATM sales disclosed in next 10-Q, or Form 4 sales by insiders ahead of it.
What would prove it wrong: Non-dilutive cash event (asset sale, grant, milestone payment), OCF turning positive, or shelf withdrawn (RW).
Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.
Independent filings stitched into a thesis, each with what would confirm and what would prove it wrong.
The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K. Cash need (runway < 6 months) coexists with live selling machinery (convertible note). Base case is a discounted raise; the question is when, not if.
No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.
Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 47 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.
Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.
| Date | Signal | Evidence | Score |
|---|---|---|---|
| Aug 13, 2026 | · Form 4 burst | 8 Form 4 filings in 30 days filing | 16 |
| Aug 12, 2026 | ▼ Insider selling cluster | 4 open-market sales by 4 insider(s) (~$38,212) in 30d filing | 32 |
| Aug 12, 2026 | ▲ Insider open-market buy | 1 open-market buys by 1 insider(s) (~$5,528) in 30d: Ngai Anthony K.K. [email protected] 2026-08-11 filing | 24 |
| Aug 6, 2026 | ▼ Unregistered sale | 8-K Item 3.02 filed 2026-08-06 (accepted 16:32 ET) filing | 41 |
| Aug 6, 2026 | ▼ Convertible note | “convertible note” language in 8-K (8-K) filed 2026-08-06 filing | 39 |
| Aug 6, 2026 | ▼ New debt obligation | 8-K Item 2.03 filed 2026-08-06 (accepted 16:32 ET) filing | 34 |
| Jun 30, 2026 | ▼ Runway < 6 months | ~4.7 months runway: liquidity $13,000,000 as of 2026-06-30, burn $33,507,000/yr (annualized 180-day YTD operating cash flow [companyfacts]) filing | 39 |
VIVS VivoSim Labs, INC. · HCWB HCW Biologics Inc. · CYCU Cycurion, Inc. · BIAF bioAffinity Technologies, In · XHLD TEN Holdings, Inc. · VSEE VSEE HEALTH, INC. · screener →